Renaissance Technologies - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q3 2023$2,229
-5.1%
1,727,570
-2.9%
0.00%
+33.3%
Q2 2023$2,348
+262.9%
1,778,772
+94.2%
0.00%
+200.0%
Q1 2023$647
-31.4%
915,909
-27.2%
0.00%0.0%
Q4 2022$943
-99.9%
1,257,369
+1.9%
0.00%
-50.0%
Q3 2022$1,062,000
+55.7%
1,233,614
+102.6%
0.00%
+100.0%
Q2 2022$682,000
+114.5%
608,909
+114.6%
0.00%
Q1 2022$318,000
-9.9%
283,800
+28.6%
0.00%
Q4 2021$353,000
-63.4%
220,600
-44.7%
0.00%
-100.0%
Q3 2021$965,000
+6.7%
398,900
+39.9%
0.00%0.0%
Q2 2021$904,000
+0.4%
285,100
+6.7%
0.00%0.0%
Q1 2021$900,000
-30.0%
267,200
-25.6%
0.00%0.0%
Q4 2020$1,286,000
+2196.4%
359,200
+1594.3%
0.00%
Q3 2020$56,000
-63.6%
21,200
-57.9%
0.00%
Q2 2020$154,000
-62.8%
50,400
-60.1%
0.00%
Q4 2019$414,000
-16.4%
126,323
-24.0%
0.00%
Q3 2019$495,000
+0.2%
166,123
-15.2%
0.00%
Q2 2019$494,000195,9230.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q1 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 1,854,278$6,638,0003.61%
Asymmetry Capital Management, L.P. 739,812$2,649,0001.21%
Affinity Asset Advisors, LLC 625,000$2,238,0001.19%
Tri Locum Partners LP 728,710$2,609,0000.95%
Boxer Capital, LLC 6,226,673$22,291,0000.72%
DAFNA Capital Management LLC 668,148$2,392,0000.71%
Vivo Capital, LLC 4,220,938$15,111,0000.67%
Delphi Management Partners VIII, L.L.C. 256,734$919,0000.60%
SILVERARC CAPITAL MANAGEMENT, LLC 280,000$1,002,0000.58%
Rubric Capital Management LP 1,853,417$6,635,0000.49%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders